Cumberland Pharmaceuticals

Cumberland Pharmaceuticals products

A

• Acetadote® – acetylcysteine (injection)

  • Indication: Treatment of acetaminophen (Tylenol) overdose to prevent liver injury (acute-care emergency use).

C

• Caldolor® – ibuprofen (injection)

  • Indication: Management of moderate to severe pain and fever in adults and children; also used as an adjunct to opioids.

K

• Kristalose® – lactulose oral solution

  • Indication: Treatment of acute and chronic constipation (gastroenterology).

S

• Sancuso® – granisetron transdermal patch

  • Indication: Prevention of chemotherapy-induced nausea and vomiting (CINV); applied before chemotherapy and lasts several days.

V

• Vaprisol® – conivaptan (injection)

  • Indication: Treatment of hospitalized patients with euvolemic or hypervolemic hyponatremia (low blood sodium).

• Vibativ® – telavancin (injection)

  • Indication: Treatment of serious Gram-positive infections, including hospital-acquired/ventilator-associated bacterial pneumonia and complicated skin and skin structure infections.

Pipeline / Investigational

• Dyscorban (ifetroban oral capsule)

• Publicly advancing in Phase II trials for cardiomyopathy associated with Duchenne muscular dystrophy (DMD); has received FDA Orphan Drug and Rare Pediatric Disease designations.